Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month
BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) -- During National Sleep Awareness…
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026
March 10, 2026 08:05 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper
ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC),…
LECTRA : Monthly declaration of the total number of shares and voting rights composing the company’s capital (at February 28th,2026)
Monthly declaration of the total number of shares and voting rights composing…
Darktrace Appoints Ed Jennings as President and CEO
Veteran Leader Brings Deep Software and Cybersecurity Experience March 09, 2026 13:00…
Dstillerys Melinda Han Williams Named to ADWEEKs AI Power 50
Dstillery Chief Data Scientist recognized for AI innovation March 09, 2026 12:52…
Surgery Partners, Inc. to Present at Upcoming Investor Conference
March 09, 2026 12:04 ET | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 09, 2026 12:01 ET | Source: Zealand Pharma Press release –…
CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3…
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
March 08, 2026 14:00 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
